Lenz & Staehelin advised co-lead investors Samsara Biocapital and Lightspeed Venture Partners as their Swiss counsel. VISCHER advised ImmunOs. Walder Wyss advises Gimv. ImmunOs Therapeutics AG,...
ImmunOs Therapeutics’ CHF 71 Million Series B Financing Round
Vail Resorts’ Acquisition of Majority Stake in Andermatt-Sedrun Sport AG
Lenz & Staehelin advised Vail Resorts on this transaction. Advestra advised Andermatt Swiss Alps AG (ASA). Vail Resorts (NYSE: MTN) has announced that it will acquire...
Vail Resorts’ Acquisition of Majority Stake in Andermatt-Sedrun Sport AG
Lenz & Staehelin advised Vail Resorts on this transaction. Advestra advised Andermatt Swiss Alps AG (ASA). Vail Resorts (NYSE: MTN) has announced that it will acquire...
Prysmian Group’s CHF 18.8 Million Acquisition of Omnisens
Lenz & Staehelin advised Prysmian Group on the deal. Tavernier Tschanz acted as counsel to the sellers in this transaction, including Renaissance PME fondation suisse d’investissement,...
Müller Steinag Holding’s Acquisition of Creabeton Matériaux
Lenz & Staehelin advised Vicat and Vigier Holding in this transaction. MLL advised Müller-Steinag. Vicat Group, the Euronext listed producer of cement, concrete and aggregates announced...
Fahrzeug-Werke Lueg AG’s Acquisition of Schulhausgarage AG
Lenz & Staehelin acted as counsel to Fahrzeug-Werke Lueg AG. Fahrzeug-Werke LUEG AG (one of the largest mobility provider in Germany and a leading sales and...
Coop’s Acquisition of Jumbo-Markt AG
Lenz & Staehelin acted as lead counsel to Maus Frères in this transaction, while Niederer Kraft Frey advised Coop. Maus Frères and Coop-Gruppe Genossenschaft announced the...
Bain Capital And Cinven’s CHF 4.2 Billion Acquisition of Lonza’s Specialty Ingredients Business
Bär & Karrer has acted as lead counsel to Lonza in this transaction. Lenz & Staehelin, Freshfields Bruckhaus Deringer, Kirkland & Ellis and Elvinger Hoss Prussen...